Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Tight bollies on DWLD.
Moneyflow positive
Buzz--watch DWLD
Looking for a swing up here. TOTALLY Oversold.
Double bottom?
ICEW --may be early but the money flow is positive.
---Looks Oversold. But stocks can stay "Oversold" for awhile. SO, this one goes on my Watch LIST.
IPVO IS bouncing down here.
Thanks for the heads up, capitalidea. Probably needs to be over .64 to buy some more.
ICEW chart shows volume coming in....and at a long base.
ICEW chart shows volume coming in
[chart[]chart.bigcharts.com/bc3/intchart/frames/chart.asp?symb=icew&compidx=aaaaa%3A0&ma=1&maval=10&uf=32&lf=1&lf2=256&lf3=8&type=4&size=2&state=8&sid=1152909&style=320&time=8&freq=1&comp=NO%5FSYMBOL%5FCHOSEN&nosettings=1&rand=2973&mocktick=1
Keep on running, DCUT.
ADVR news may make it do a long awaited bottom reversal. Their Clinical results out o fthe ASCO conference were great. Check the PR.
But the chart shpws tight Bollinger Bands...and an Oversold condition. One to watch at tomorrow morning's open.
oldpro--show a chart of DCUT
IPVO .80
Rigatoni, IPVO has just turned up--and crossed the 10 day moving average. Could you put up one of your charts
[chart}chart.bigcharts.com/bc3/intchart/frames/chart.asp?symb=ipvo&compidx=aaaaa%3A0&ma=1&maval=10&uf=0&lf=1&lf2=2&lf3=512&type=4&size=2&state=8&sid=1317631&style=350&time=7&freq=1&comp=NO%5FSYMBOL%5FCHOSEN&nosettings=1&rand=4108&mocktick=1{/chart]
IPVO news
IPVoice Communications Inc. Announces Chinese Joint Venture with $1 Million in Contracted Revenues
Tuesday June 1, 1:56 pm ET
IPVoice and GaozhiSoft Open Office to Market IPVoice Products and Services in China
Thanks, babycakes. Service with a smile.
Looks like FPPC needs to see $1.45 and it could really go then. Volume pick up is encouraging.
baby cakes--could you do one of your charts for FPPC? Your software has more variables than I can get.
TIA
FPPC just got through the 10DMA and On Balance Volume continues up. Money flow positive too.
Omni, what volume level do you look for before you see it as significant. FPPC' average volume is low-- but I like that it is a Narual Gas play.
TFCT is a swinger.
IPVO does look like it could BOING here.
lance, where would you get in? Wait for .074?
Rigatoni!! Jeez --look at that spread on USEG.
This thing could fly-- when you get a spread from ONE TRADE--in my experience, it is a prelude to an upside move.
Money flow on FPPC looks like a swing up is due.
Riga, you might want to keep watch on USEG (natural gas play).
Take a look at its long base building near its 2 year lows. I would not get in unless its volume increases 2-3 times...and it getsover $2.45. But if that happens, it could run..IMO.
Thanks, Missy, for the IPVO chart. I really think IPVO is goingto go--nudging its nose at the 10 day.
Could you do one on MAGR? That woke up this afternoon.
Hello, Missy. Bottom bounce in progress.
How do your charts look?
omni, what does this chart on IPVO say to you?
DCUT is now on the pinks and trading at .025
You are right on DCUT.
Now at .025
IPVO chart looks like one to play for a bounce. Looks like breaking through the 10 DMA could get it back to $1.00. Bounced off .62 two days ago.
DCUTE went to the pink sheets last night.
Hope they get that E off and the filings done pronto. Did you talk to the company, ekim?
IPVO is on Bounce Play Watch
Check this one out--NUEP-- not alot of volume (although it looks like today's volume is three times normal). Do not know much about the company other than the S-1 filing today was what investors wanted to have happen. Could be a short, according to a colleague. He mentioned TASR as an example--but that may be more hopeful than reality.
Mach--Not ZKEM
XKEM
And who is Pandy?
TIA
Thanks,Mach. What do you think about XKEM?
The Press release below talks about their clinical trial results for sickle cell anemia,,,and thos results are about ot be published in a Medical Journal (June Issue)
May explain a few things.
Xechem Presents Update on NIPRISAN -- Nix-0699 at Annual Meeting of the National Sickle Cell Disease Program; Projects Filing IND Before Year End
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--April 27, 2004--On April 20, 2004, Xechem International, Inc. (OTC BB:XKEM) and Dr. Peter N. Gillette, a Sickle Cell Disease Clinician from the State University of New York (SUNY) at Brooklyn co-presented their latest results in the ongoing evaluation of NIPRISAN (new names NICOSAN(TM)/HEMOXIN(TM)) through in-vitro and in-vivo analyses. The information was presented at the 27th Annual Meeting of the National Sickle Cell Disease Program: Therapy for Sickle Cell Disease: Making Promise a Realty this past week in Los Angeles, CA.
Dr. Gillette reported results of Nigerian toxicity studies in animals which demonstrated LD50 (dose at 50% animal death) of 2000-5000 mg per kg of animal weight. This is an unusually safe margin since the early human studies were at 12-15 mg per kg. Additional pharmacologic studies showed no significant organ damage.
Additional findings from the clinical studies performed in Nigeria and work done at Xechem suggest that twice daily administration could be more effective and that higher doses might be well tolerated. Additional dose escalation and schedules are being planned for Phase III clinical trials in Nigeria. To date, Phase I and Phase II clinical studies in Nigeria suggest that NIPRISAN appears to be an efficacious anti-sickling drug, well tolerated, and toxicity, thus far, is acceptable.
Xechem cited significant progress during the last six months through ongoing research in the quality control and standardization of NIPRISAN as a phyto-pharmaceutical. According to Dr. Ramesh C. Pandey, Chairman & CEO of Xechem International, Inc., these studies are close to completion. Dr. Pandey believes upon successful completion of the standardization research, Xechem will be in a position to file its Investigational New Drug ("IND") application to FDA for HEMOXIN(TM), already under Orphan Drug designation by year end.
On Sept. 2, 2003, Xechem International, Inc. ("Xechem") announced that it received Orphan Drug designation from the U.S. Food and Drug Administration ("FDA"), Office of Orphan Drug Products Development for NIPRISAN, under the name HEMOXIN(TM), as a phyto-pharmaceutical drug for the treatment of patients suffering with Sickle Cell Disease ("SCD").
According to a study published by Allison Ashley-Koch, Quanhe Yang, and Richard S. Olney of the Centers for Disease Control and Prevention ("CDC"), Sickle Cell Disease is a major public health concern. Each year in the US, an average of 75,000 hospitalizations are due to Sickle Cell Disease, costing approximately $475 million. The average length of stay per hospital visit was 6.1 days and adults tended to have longer stays than children and adolescents.
IDGE chart would help, LOL.
Up through the 10 Day Moving Average.
CLosed at High of Day
Volume healthy
Notice that IDGE closed at its high of the day?
That has not happpened for weeks... opening tomorrow should be interesting.
XKEM chart shows breakout potential.
It came back from its High of the Day...but the volume says XKEM should be monitored.
Double Bottom chart on USEG
Needs more volume--but just shifted into Accumulation. And talk about oversold. Good sector--natural gas production.
Thanks on IDGE. IT seems to get strong in the morning-and fad in the afternoon. Probably getting through that S-8.
Just bough tsome more at .0028---and waiting. It worked for me in ONEV...
IPVO had a good close. Whew!
And turning into ACCUMULATION again.
Sometimes I wonder if I do not trade enough. I sold half at 1.20--but hung on to the rest.
Watching IPVO's close today.
For obvious reasons...
Very weak market today...and IPVO is hanging in there on average volume. Couldbe a turning point? I would appreciate anybody's interpretation on this chart--and thanks in advance.
Like this IDGE chart.
Lots of volume--no movement. Really looking like nothing is happening.
love that look.